Why the study?
Does ivabradine reduce heart rate and improve symptoms in patients with persistent and β-blocker-resistant inappropriate sinus tachycardia after successful RF ablation of the atrioventricular node slow pathway?
Does ivabradine reduce heart rate and improve symptoms in patients with persistent and β-blocker-resistant inappropriate sinus tachycardia after successful RF ablation of the atrioventricular node slow pathway?
Ivabradine effectively reduces heart rate and improves symptoms in patients with beta-blocker-resistant inappropriate sinus tachycardia following slow pathway ablation.
No takes yet. Share an insight, caveat, or question.
May support ivabradine in β-blocker-resistant IST post-ablation; leaves open confirmation in randomized trials.
Ptaszyński et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: